Type-A synthesis (a structure induced across sources, present as a general claim in none). Two dietary exposures the wiki holds — saturated fat and sodium — share one shape: the guideline is rated most certain about the surrogate and least certain about the patient-important outcome the surrogate stands for. Each source states its own split; neither states the regularity, and neither holds the counter-instance that reveals what actually drives it.
The pattern — matched on within-exposure certainty
The compared parameter is GRADE certainty on the surrogate vs certainty on the patient-important outcome, within the same guideline’s own evidence profile — both grades are the body’s own, on the same exposure, so this is like-for-like.
| Exposure | Surrogate — certainty | Patient-important outcome — certainty | Gap | Carrier page |
|---|---|---|---|---|
| Reduce saturated fat | LDL cholesterol — HIGH | CVD events — Moderate; all-cause mortality — Moderate (null) | 1 level | Saturated Fat Intake and Replacement |
| Reduce sodium | blood pressure — HIGH | direct cohort hard outcomes — VERY LOW (fatal stroke Low; one 2-RCT CVD estimate Moderate) | up to 3 levels | Sodium Intake and Blood Pressure |
In both cases the best-known quantity is the marker, not the outcome. WHO’s sodium guideline makes the move explicit — because the direct outcome evidence is very low, «the evidence of an effect of sodium on blood pressure was also considered moderate-quality evidence that reduced sodium is beneficial for reducing risk of cardiovascular disease» — the outcome recommendation is carried by the surrogate, transferred down one level (WHO Sodium Annex 8, on Sodium Intake and Blood Pressure). The sodium gap quoted above is floor-to-ceiling; the effective gap after that transfer is narrower.
(World Health Organization, 2012) (World Health Organization, 2023)
The counter-instance, and what it reveals about the cause
The inversion is NOT a law, and physical activity breaks it: it is rated HIGH certainty on all-cause mortality itself — a patient-important outcome, no surrogate needed (total activity HR 0.34, 0.27-0.43, HIGH; on Physical Activity Dose and Mortality). There is no gap to invert.
Attempting this contradiction relocates the cause — and the first candidate cause fails. The obvious story is self-reported diet flattens the outcome signal. Sodium refutes it: sodium exposure is objectively measured — urinary sodium is a recovery biomarker, absolute not self-reported (Measurement Error in Dietary Assessment) — yet sodium carries the widest outcome-certainty gap of any exposure here. If self-report were the driver, the best-measured exposure would not be the worst-graded on outcomes.
So the driver is the availability of credible hard-outcome evidence, not how the exposure is measured:
- sodium’s hard-outcome evidence is cohort (very low), because almost no trials randomised people to a sodium intake and followed them to events; its blood-pressure evidence is 36 RCTs (high);
- physical activity’s HIGH grade rests on eight harmonized cohorts, all device-measured, with a mortality endpoint — the outcome itself has been studied at scale;
- self-report is a real aggravator on the diet side but a secondary one — it is why SFA’s observational mortality estimate is graded Very low, but it is not why sodium’s is.
The inversion is therefore a symptom of thin hard-outcome trial evidence meeting a well-studied marker — wherever the outcome has been tried (or measured in large objective cohorts), certainty can attach to the outcome directly. (inferred from World Health Organization, 2012, 2020, 2023)
Why carbohydrate restriction is NOT a third instance
It looks like one — HbA1c is graded High at 6 months while medication-free remission is Low (Carbohydrate Restriction and Type 2 Diabetes Remission) — but the structure differs. HbA1c does not stand for remission; remission is defined as an HbA1c threshold, so this is a marker against a stricter cut of the same marker (plus medication status), not a surrogate standing for a distinct patient-important outcome (events, death). Its lower certainty comes from few, short trials and medication withdrawal, not from a surrogate-to-outcome transmission gap. Recorded as a distinction, not folded in — including it would stretch the pattern to fit.
Why it is a decision-change, not a curiosity
When a dietary guideline sounds confident, check what the confidence is attached to. For these exposures it attaches to a marker (LDL, blood pressure), and the patient-important outcome sits one to three levels lower — so:
- Discount confident surrogate-based dietary advice toward the outcome’s certainty, not the marker’s -> Surrogate Outcomes. A strong recommendation resting on high LDL evidence is not a strong claim that fewer people die — the SFA guideline is the worked case (strong recommendation, HIGH on LDL, all-cause mortality a Moderate-certainty null).
- What would raise the certainty is a hard-outcome trial, not another marker study — the gap does not close by measuring LDL or blood pressure more precisely.
Limits
- Two instances and one counter-instance — a pattern with a boundary, not a proven law.
- Not independent corroboration. Both inverted instances are WHO guidelines applying the same GRADE
machinery, so their shared shape is partly a shared method, not two independent witnesses — which is
itself part of the finding (the inversion may be as much a property of how GRADE meets thin outcome
evidence as of the evidence). No
[E-independent]. - Coherence, not validity (method-risks R1): the pattern says where guidance is certain, not where it is right. A high-certainty surrogate may transmit to the outcome exactly as claimed; the inversion is about warrant, not truth.
Self-critique [run 2026-07-28, before commit — two defects caught and fixed]
- The first mechanism was self-refuting and was replaced. The draft blamed self-reported diet and listed sodium among the self-reported exposures — but sodium is objectively measured (recovery biomarker) and has the widest gap, which falsifies that mechanism. Corrected to hard-outcome trial sparsity, with sodium as the proof rather than an example of self-report.
- A stretched instance was removed. Carbohydrate restriction was dropped from the pattern (HbA1c is the remission-defining marker, not a surrogate for a distinct outcome) and re-filed as a distinction — the not-joined discipline over instance-count.
- Parameter-table discipline: the matched quantity is within-exposure certainty (surrogate vs outcome), both grades from the same body’s own profile — not LDL compared to blood pressure across exposures.
- Independence checked and denied: both instances are WHO/GRADE — recorded as a limit, no E-claim.